LUMISTOBART
UNII 6GCR77W6UZ

Substance Identification & Data

This profile provides standardized clinical and technical data for Lumistobart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6GCR77W6UZ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2851923-91-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6GCR77W6UZ

CAS Registry Number

2851923-91-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LUMISTOBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C187653

National Cancer Institute reference terminology for clinical and research data.

INN ID

13012

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lumistobart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LUMISTOBART

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN HUMANIZED (1-448) (VH (HOMO SAPIENS IGHV4-31*02 (93.9%) -(IGHD) -IGHJ4*01 (86.7%) L123>T (113), CDR-IMGT (9.7.11) (26-34.52-58.97-107)) (1-118) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 CH1 K120, CH3 E12, M14, G1V29 CH2 A84.4 (CH1 R120>K (215) (119-216), HINGE 1-15 (217-231), CH2 N84.4>A (298) (232-341), CH3 E12 (357), M14 (359) (342-446), CHS (447-448)) (119-448)), (221-220')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HUMANIZED (1'-220') (V-KAPPA (HOMO SAPIENS IGKV4-1*01 (91.1%) -IGKJ2*01 (100%), CDR-IMGT (12.3.9) (27'-38'.56'-58'.95'-103')) (1'-113') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (159'), V101 (197') (114'-220')); DIMER (227-227'':230-230'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-S, NON-GLYCOSYLATED

IMMUNOGLOBULIN G1, ANTI-(HUMAN SIGNAL REGULATORY PROTEIN .ALPHA.) (HUMAN-MUS MUSCULUS MONOCLONAL BR105 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BR105 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS SIRPA (SIGNAL REGULATORY PROTEIN ALPHA, SHPS1, PROTEIN TYROSINE PHOSPHATASE NONRECEPTOR TYPE SUBSTRATE 1, PTPNS1, SIRP, SIRP ALPHA, CD172A)), HUMANIZED MONOCLONAL ANTIBODY

LUMISTOBART [INN]